Lv4
514 积分 2025-04-28 加入
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
13天前
已完结
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.1
13天前
已完结
中国老年人维生素D缺乏管理指南（2026版）
14天前
已完结
ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib
15天前
已完结
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study
15天前
已完结
胃癌影像学检查与诊断规范化流程专家共识（2022版）
23天前
已完结
Diabetes Management in Detention Facilities: A Statement of the American Diabetes Association
1个月前
已完结
Diabetes Management in Detention Facilities: A Statement of the American Diabetes Association
1个月前
已关闭
A procalcitonin-based algorithm to guide antibiotic use in patients with acute pancreatitis (PROCAP): a single-centre, patient-blinded, randomised controlled trial
1个月前
已完结
Pediatric hemophagocytic lymphohistiocytosis: current conceptualization, diagnosis, and treatment
2个月前
已完结
皖公网安备34019202002308
